Eton Pharmaceuticals (ETON) Profit After Tax (2018 - 2026)

Eton Pharmaceuticals has disclosed Profit After Tax across 9 years of filings, most recently posting $11.6 million for Q2 2026.

• In Q2 2026, Profit After Tax rose 547.89% year-over-year to $11.6 million; the TTM figure through Jun 2026 stood at $8.5 million (up 307.1% YoY), while the FY2025 annual figure was -$4.6 million, down 20.35% from the prior year.
• Profit After Tax came in at $11.6 million for Q2 2026 at Eton Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $11.6 million in Q2 2026 to a low of -$5.3 million in Q1 2022.
• Average Profit After Tax over 5 years is -$400176.5, with a median of -$1.6 million recorded in 2022.
• Year-over-year, Profit After Tax slumped 407.34% in 2025 and surged 547.89% in 2026.
• Over 5 years, Profit After Tax stood at $912000.0 in 2022, then sank by 347.37% to -$2.3 million in 2023, then soared by 73.49% to -$598000.0 in 2024, then jumped by 347.99% to $1.5 million in 2025, then surged by 680.71% to $11.6 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $11.6 million in Q2 2026, $1.5 million in Q4 2025, and -$1.9 million in Q3 2025.